AQR Capital Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.3M Buy
988,973
+377,585
+62% +$2.63M ﹤0.01% 1602
2025
Q4
$4.3M Sell
611,388
-59,682
-9% -$360K ﹤0.01% 1664
2025
Q3
$3.69M Buy
671,070
+643,057
+2,296% +$3.15M ﹤0.01% 1624
2025
Q2
$145K Sell
28,013
-23,487
-46% -$141K ﹤0.01% 3116
2025
Q1
$343K Buy
51,500
+35,554
+223% +$270K ﹤0.01% 2630
2024
Q4
$118K Buy
+15,946
New +$114K ﹤0.01% 2750
2024
Q2
Sell
-31,334
Closed -$193K 2643
2024
Q1
$193K Buy
31,334
+10,681
+52% +$71.9K ﹤0.01% 2257
2023
Q4
$162K Sell
20,653
-12,991
-39% -$83.7K ﹤0.01% 2241
2023
Q3
$231K Buy
+33,644
New +$273K ﹤0.01% 2096

Other funds holding LFST

AQR Capital Management's LFST Position: Q1 2026 in Review

AQR Capital Management increased its Lifestance Health (LFST) stake by 62% in Q1 2026, buying an estimated $2.63M and bringing the position to 988,973 shares worth $6.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

AQR Capital Management first reported a position in LFST in Q3 2023 and has held it in 9 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • AQR Capital Management held 988,973 shares of Lifestance Health worth $6.3M as of Q1 2026.
  • AQR Capital Management bought 377,585 Lifestance Health shares in Q1 2026, an estimated $2.63M.
  • Lifestance Health made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1602 holding.
  • AQR Capital Management first reported a position in Lifestance Health in Q3 2023 and has held it in 9 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.